This CME initiative is designed to meet the educational needs of urologists, medical oncologists, oncology nurses, and other health care providers involved in the treatment of patients with prostate cancer.
This live activity will review newly approved and investigational agents and combinations of agents that may improve outcomes for patients with relapsed, refractory follicular lymphoma (FL). Traditionally, FL has been associated with the development of aggressive disease and poor outcomes for many patients. The ongoing development of new compounds with unique mechanisms of action extends the available treatment options for patients across all lines of therapy, with an emphasis on personalization of care.
This live activity is focused on the care of patients with early HER2-positive breast cancer.
This live activity will cover the treatment and management of patients with metastatic, hormone receptor-positive, HER-2 negative breast cancer.
This CME initiative is designed to meet the educational needs of urologists, medical oncologists, oncology nurses, and other health care providers involved in the treatment of patients with prostate cancer.
This live activity will review newly approved and investigational agents and combinations of agents that may improve outcomes for patients with relapsed, refractory follicular lymphoma (FL). Traditionally, FL has been associated with the development of aggressive disease and poor outcomes for many patients. The ongoing development of new compounds with unique mechanisms of action extends the available treatment options for patients across all lines of therapy, with an emphasis on personalization of care.
This case-based live activity will cover the treatment and management of patients with multiple sclerosis (MS).
This live activity will review newly approved and investigational agents and combinations of agents that may improve outcomes for patients with relapsed, refractory follicular lymphoma (FL). Traditionally, FL has been associated with the development of aggressive disease and poor outcomes for many patients. The ongoing development of new compounds with unique mechanisms of action extends the available treatment options for patients across all lines of therapy, with an emphasis on personalization of care.
This case-based live activity will cover the treatment and management of patients with multiple sclerosis (MS).
This live activity will cover the treatment and management of patients with metastatic, hormone receptor-positive, HER-2 negative breast cancer.
This live activity will cover the treatment and management of patients with metastatic, hormone receptor-positive, HER-2 negative breast cancer.
This initiative is designed to meet the educational needs of ER physicians and hematologist-oncologists involved in the treatment of patients with hemophilia.
Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.
We are thrilled to announce that we have been recognized as one of the Top 10 Health Education Services Providers by Healthcare Business Review!
This award is both an honor and a testament to our cumulative dedication to providing the best continuing medical education (CME) services to HCPs across the globe. We are proud to be part of this distinguished group and look forward to continuing to have MLG be one of the best CME providers in the country.
Thank you to Healthcare Business Review for this recognition and for shining a light on the importance of accurate and accessible healthcare education.
The Best of America Small Business Website award recognizes the best website launched by a small business since 2021. Technology is a key growth enabler for small businesses. The best in tech track recognizes small businesses as experts in technology and innovation from innovators, app developers, and website creators. Visit our award-winning Ophthalmology and Optometry web portal: vision-relief.com
Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.
Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.
